Filing Details
- Accession Number:
- 0001645627-18-000055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-10 14:34:06
- Reporting Period:
- 2018-09-05
- Accepted Time:
- 2018-09-10 14:34:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 38,000 shares | Avg. Price: $0.04 | Total Value: $1,684.50 |
| Number of Shares After Transactions: | 25,893,198 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-09-05 | 2,000 | $0.05 | 25,857,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 3,000 | $0.05 | 25,860,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,861,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 2,000 | $0.05 | 25,863,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,864,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,865,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,866,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 2,000 | $0.05 | 25,868,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,869,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,870,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,871,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,872,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,873,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,874,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,875,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-05 | 1,000 | $0.05 | 25,876,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.05 | 25,777,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.05 | 25,878,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.05 | 25,879,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.04 | 25,880,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.04 | 25,881,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.04 | 25,882,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.04 | 25,883,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 2,000 | $0.04 | 25,885,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 3,000 | $0.04 | 25,888,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 500 | $0.04 | 25,888,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.04 | 25,889,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 2,000 | $0.04 | 25,891,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 500 | $0.04 | 25,892,198 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-09-06 | 1,000 | $0.04 | 25,893,198 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
